NAM is the official provider of online scientific news for IAS 2013

Greta Hughson
Published: 18 June 2013

The 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) is taking place in Kuala Lumpur, Malaysia, later this month.

NAM is delighted to have been selected as official provider of scientific news reporting for this conference by the International AIDS Society and we will be working hard to share news from the conference with you.

We’ll be reporting on key research presented at the conference, publishing news online at and sending out news summary bulletins by email, four during the conference week and one the following week.

You can expect to read news reports covering major new research on:

  • Progress towards an HIV cure
  • New WHO antiretroviral treatment guidelines
  • Pre-exposure prophylaxis, including results of a study of PrEP among people who inject drugs
  • The impact of treatment as prevention
  • Improvements in antiretroviral therapy for adults and children.

Our conference bulletins will be sent out by email in English, French, Italian, Portuguese, Russian and Spanish. You can sign up, free of charge, at

“The coverage made me feel I was at the conference and I appreciate NAM's effort in sharing the bulletins.” NAM bulletin subscriber

What is IAS 2013?

The IAS conference takes place every two years, each time in a different location. It is a scientific conference and aims to bring together people working in HIV to share the latest HIV-related research.

The conference organisers expect around 5000 people to attend this year.

“It is a unique opportunity for the world’s leading scientists, clinicians, public health experts and community leaders to examine the latest developments in HIV-related research, and to explore how scientific advances can – in very practical ways – inform the global response to HIV/AIDS.” (

The conference programme is available online, with abstracts and details of speakers, so you can find out more about the conference sessions and plan your days if you are attending the conference. Once the conference is underway, video highlights and slides from some of the presentations will be available online.

This is the first time the IAS conference has been held in Asia. The conference organisers chose Malaysia in part because of its “leadership in the area of HIV prevention for people who use drugs and the commitment of the Malaysian government to provide free HIV treatment to all Malaysians in need of antiretroviral therapy.”

There is much more information about the conference on the official website:

Clinical Care Options

The other official online science provider for IAS 2013 is Clinical Care Options (CCO).

CCO is providing scientific analysis for delegates and journalists, delivered through online continuing medical education (CME) activities.

Coverage from CCO will include capsule summaries of the most clinically relevant studies, selected by the CCO’s expert faculty; audio podcasts of the day’s highlights; downloadable PowerPoint slides summarising key data; and analysis of the clinical implications of the major studies from a panel of international experts.

Sharing knowledge, changing lives

You can help us to share the latest research in HIV.

You could share links to news stories or bulletins by email, in newsletters, on blogs or other social media like Facebook and Twitter.

Before the conference begins you can help by letting your contacts, forums and email lists know they can sign up to receive the free bulletins.

Here’s an example you could tweet: Get the latest #HIV news from #IAS2013 from @aidsmap – sign up for free email bulletins during the conference at

If you would like to feature our conference news on your website, or receive it in a newsreader, visit the news feeds section of our conference webpages for more information and RSS feeds.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.